6-106512832-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001371242.2(CRYBG1):c.1715C>T(p.Pro572Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,577,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001371242.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CRYBG1 | NM_001371242.2 | c.1715C>T | p.Pro572Leu | missense_variant | 3/22 | ENST00000633556.3 | |
CRYBG1 | NM_001624.4 | c.491C>T | p.Pro164Leu | missense_variant | 1/20 | ||
CRYBG1 | XM_047418270.1 | c.1793C>T | p.Pro598Leu | missense_variant | 4/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CRYBG1 | ENST00000633556.3 | c.1715C>T | p.Pro572Leu | missense_variant | 3/22 | 5 | NM_001371242.2 | P1 | |
CRYBG1 | ENST00000651520.1 | c.1556C>T | p.Pro519Leu | missense_variant | 2/2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000154 AC: 22AN: 1425740Hom.: 0 Cov.: 37 AF XY: 0.0000184 AC XY: 13AN XY: 705800
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152238Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2021 | The c.491C>T (p.P164L) alteration is located in exon 1 (coding exon 1) of the AIM1 gene. This alteration results from a C to T substitution at nucleotide position 491, causing the proline (P) at amino acid position 164 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at